食管癌VMAT-IMRT不同纵向边界的DVH与NTCP剂量学比较
该回顾性研究选取10例食管中下段鳞癌患者,为每例定义纵向边界4cm、3cm、2cm(轴向边界均为1.5cm)的三个PTV,分别计算41.4Gy新辅助与50.4Gy根治两种剂量计划,采用DVH和NTCP方法比较肺、心脏、脊髓和肝脏的剂量。结果显示纵向边界从4cm缩至3cm可显著降低肺全部剂量参数(除Dmax)及心脏Dmean和V5,缩至2cm进一步降低肺和心脏多个参数并显著降低放射性肺炎NTCP风险。
要点
- 纵向边界4cm缩至3cm可显著降低肺剂量(除Dmax)及心脏Dmean与V5。
- 纵向边界缩至2cm可显著降低新辅助和根治计划的放射性肺炎NTCP风险。
- 心脏中位剂量在4cm与2cm边界间未见差异。
核心结论
- 纵向边界从4cm缩至3cm可显著降低肺剂量和心脏Dmean,缩至2cm可进一步降低放射性肺炎NTCP风险,但临床获益与肿瘤学结局仍不明确。
研究设计与样本
- 回顾性选取10例食管中下段鳞癌患者,每例定义纵向边界4cm、3cm、2cm(轴向边界1.5cm)的三个PTV。
- 每个PTV分别计算总剂量41.4Gy(新辅助治疗)和50.4Gy(根治治疗)两种VMAT-IMRT计划。
- 采用DVH和NTCP方法评估并比较肺、心脏、脊髓和肝脏的剂量。
主要发现
- 纵向边界3cm较4cm时,肺除Dmax外所有剂量参数(Dmin、Dmean、Dmedian和V5-V35)均显著降低。
- 纵向边界3cm较4cm时,心脏Dmean和V5显著降低,Dmin、Dmax、Dmedian和V10-V35未见显著降低。
- 纵向边界2cm较4cm时,肺Dmin、Dmean、Dmedian和V5-V35及心脏Dmax、Dmean和V5-V35均见显著差异,但心脏中位剂量无差异。
- 根治计划采用3cm边界时心脏V10进一步降低。
- 纵向边界缩至2cm时,新辅助和根治计划的放射性肺炎NTCP风险均显著降低。
临床怎么用
- 在集成先进诊断影像进行靶区勾画的前提下,可考虑将食管鳞癌纵向边界从4cm缩至3cm以减少肺和心脏剂量。
- 纵向边界缩至2cm可能进一步降低放射性肺炎NTCP风险,但需后续研究评估临床获益与肿瘤学结局。
局限性
- 临床获益和肿瘤学结局仍不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To cover the microscopic tumor spread in squamous cell carcinoma of the esophagus (SCC), longitudinal margins of 3-4 cm are used for radiotherapy (RT) protocols. However, smaller margins of 2-3 cm might be reasonable when advanced diagnostic imaging is integrated into target volume delineation. Purpose of this study was to compare the dose distribution and deposition to the organs at risk (OAR) for different longitudinal margins using a DVH- and NTCP-based approach. METHODS: Ten patients with SCC of the middle or lower third were retrospectively selected. Three planning target volumes (PTV) with longitudinal margins of 4 cm, 3 cm and 2 cm and an axial margin of 1.5 cm to the gross target volume (GTV) were defined for each patient. For each PTV two treatment plans with total doses of 41.4 Gy (neoadjuvant treatment) and 50.4 Gy (definite treatment) were calculated. Dose to the lungs, heart, myelon and liver were then evaluated and compared between different PTVs. RESULTS: When using a longitudinal margin of 3 cm instead of 4 cm, all dose parameters (Dmin, Dmean, Dmedian and V5-V35), except Dmax could be significantly reduced for the lungs. Regarding the heart, a significant reduction was seen for Dmean and V5, but not for Dmin, Dmax, Dmedian and V10-V35. When comparing a longitudinal margin of 4 cm to a longitudinal margin of 2 cm, a significant difference was calculated for Dmin, Dmean, Dmedian and V5-V35 of the lungs and for Dmax, Dmean and V5-V35 of the heart. Nevertheless, no difference was seen for median heart dose. An additional dose reduction for V10 of the heart was achieved for definite treatment plans when using a longitudinal margin of 3 cm. The NTCP-based risk of pneumonitis was significantly reduced by a margin reduction to 2 cm for neoadjuvant and definite treatment plans. CONCLUSION: Reduction of longitudinal margins from 4 cm to 3 cm can significantly reduce the dose to lungs and Dmean of the heart. Despite clinical benefit and oncologic outcome remain unclear, reduction of the longitudinal margins might provide the opportunity to reduce side effects of chemoradiation (CRT) for SCC in upcoming studies.
引用
- Münch S, Oechsner M, Combs SE, et al. DVH- and NTCP-based dosimetric comparison of different longitudinal margins for VMAT-IMRT of esophageal cancer. Radiat Oncol. 2017. PMID: 28806990. doi:10.1186/s13014-017-0871-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。